CD19/CD20 dual-targeted cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19/CD20 dual-targeted cell therapy, covering 2024-11-06 to 2024-11-06. Get the full timeline:
Most recent: Clinical Trial Update: Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma [Phase 1]